Interventions Targeting Absences Increase Adherence and Reduce Abandonment of Childhood Cancer Treatment in El Salvador
Keywords:
Adherence, Childhood cancer, Developing countries, Patient tracking, Treatment abandonmentAbstract
Background. In El Salvador, about 200 new cases of pediatric cancer are diagnosed each year, and survival rates approach 70%. Although treatment is available at no cost, abandonment of therapy has remained at a steady yearly rate of 13% during the past decade. A time sensitive adherence tracking procedure (TS-ATP) was recently implemented to detect missed appointments, identify their causes, and intervene promptly. Procedure The study team was informed daily of patient/family failure to attend medical appointments in the pediatric oncology unit; the families were contacted and interviewed to ascertain and address the reasons. Patients who did not return after this initial contact were contacted again through local health clinics and municipalities. Law enforcement was a last resort for patients undergoing frontline treatment with a good prognosis. The system was adapted to clinical urgency: families of patients undergoing induction therapy were contacted within 24 hr, those in other therapy phases, within 48 hr, and those who had completed treatment, within one week. Reasons for absence were obtained by telephone or in person. Results. The annual rate of abandonment was reduced from 13– 3% during the 2 years period. There were 1,111 absences reported and 1,472 contacts with caregivers and institutions. The three main reasons for absences were financial needs (165, 23%), unforeseen barriers (116, 16%), and domestic needs (86, 12%). Conclusions. Use of the treatment adherence tracking system to locate and communicate with patients/families after missed appointments and the allocated aid stemming from these interviews substantially reduced abandonment and non-adherence
Downloads
References
Mostert S,Arora RS, Arreola M, Bagai P, Friedrich P, Gupta S, Kaur G, Koodiyedath B, Kulkarni K, Lam CG, Luna-Fineman S, Pizer B, Rivas S, Rossell N, Sitaresmi MN, Tsimicalis A, Weaver M, Ribeiro RC. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol 2011; 12:719–720
Spinetta J, Masera G, Eden T, Oppenheim D, Martins A, van Dongen Melman J, Siegleret M, Eiser C, Weyl Ben Arush M, Kosmidis HV, Jankovic M. Refusal, noncompliance, and abandonment of treatment in children and adolescents with cancer. A report of the SIOPWorking Committee on Phychosocial Issues in Pediatric Oncology. Med Pediatric Oncol 2002; 38:114– 117.
Lam C, Rossell N, Ribeiro R. Global snapshots of treatment abandonment in children and adolescents with cancer: Social factors, implications and priorities. J Healthcare Sci Hum 2012; 2:81–110.
Arora RS, Pizer B, Eden T. Understanding refusal and abandonment in the treatment of childhood cancer. Indian Pediatrics 2010; 47:1005–1010
Mostert S, Gunawan S, Wolters E, van de Ven P, Sitaresmi M, van Dongen J, Veerman A, Mantik M, Kaspers G. Socio-economic status plays important role in childhood cancer treatment outcome in Indonesia. Asian Pac JCancer Prev 2012;13:6491– 6496
Butow P, Palmer S, Pai A, Goodenough B, Luckett T, King M. Review of adherence-related issues in adolescents and young adults with cancer. J Clin Oncol 2010; 28:4800–4809
World Health Organization. Adherence to long-term therapies: Evidence for action. Sabate E, editor. Switzerland: World Health Organization; 2003. p. 194
Coccia PF, Altman J, Bhatia S, Borinstein SC, Flynn J, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Orr KM, Pappo AS, Reed D, Spraker HL, Thomas DA, von Mehren M,Wechsler DS, Whelan KF, Zebrack B, Sundar H, Shead DA. Adolescent and young adult oncology. Journal of the National Comprehensive Cancer Network. 2012; 10:1112–1150
Kondryn HJ, Edmondson CL, Hill J, Eden TO. Treatment non-adherence in teenage and young adult patients with cancer. Lancet Oncol 2011; 12:100–108
Castellano JM, Copeland-Halperin R, Fuster V. Aiming at strategies for a complex problem of medical nonadherence. Glob Heart 2013; 8:263–271
Bonilla M, Rossell N, Salaverria C, Gupta S, Barr R, Sala A, Metzger ML, Sung L. Prevalence andpredictors of abandonment of therapy among children with cancer in El Salvador. Int J Cancer 2009; 125:2144–2146
Kumar A, Moulik NR, Mishra RK, Kumar D, Causes. Outcome and prevention of abandonment in retinoblastoma in India. Pediatr Blood Cancer 2013; 60:771–775
Central Intelligence Agency. The world factbook. [Cited 2013 19 October]; Available from: https://www.cia.gov/library/publications/ the-world-factbook/geos/es.html
Israe¨ls T, Chirambo C, Caron H, de Kraker J, Molyneux E, Reis R. The guardians’ perspective on paediatric cancer treatment in Malawi and factors affecting adherence. Pediatr Blood Cancer 2008; 51:639–642.
Metzger M, Howard S, Fu L, Peña A, Stefan R, Hancock M, Zhang Z, Pui CH, Wilimas J, Ribeiro RC.Outcome of childhood acutelymphoblastic leukaemia in resource-poor countries. Lancet 2003; 362:706–708.
Li E, Jin R. Causes for refusal or abandonment during treatment of pediatric acute promyelocytic leukemia. LeukRes 2012; 36:E193.
Brown S, Belgaumi A, Kofide A, Littlechild B, Sabbah R, Ezzat A, Shoukri M, Barr R.
Levin A. Failure to attend appointments and loss to follow-up: A prospective study of patients with malignant lymphoma in Riyadh, Saudi Arabia. Eur J Cancer Care 2009; 18:313–317
Howard SC, Pedrosa M, Lins M, Pedrosa A, Pui C-H, Ribeiro RC, Pedrosa F. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004; 291:2471–2475
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Los textos académicos y científicos que se publican en la Revista La Universidad están protegidos bajo la licencia CC BY NC SA 4.0, esta permite usar una obra para crear otra obra o contenido, modificando o no la obra original, siempre que se cite al autor, la obra resultante se comparta bajo el mismo tipo de licencia y no tenga fines comerciales (https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es) . El autor es el único que pose los derechos de publicación y la Revista La Universidad posee los derechos de difusión.